REFERENCES
1. Gude NA, Sussman MA. Cardiac regenerative therapy: many paths to repair. Trends Cardiovasc Med 2020;30:338-43.
2. Yamanaka S, Blau HM. Nuclear reprogramming to a pluripotent state by three approaches. Nature 2010;465:704-12.
3. Chen Y, Lüttmann FF, Schoger E, et al. Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice. Science 2021;373:1537-40.
4. Leone M, Engel FB. Advances in heart regeneration based on cardiomyocyte proliferation and regenerative potential of binucleated cardiomyocytes and polyploidization. Clin Sci (Lond) 2019;133:1229-53.
5. Hesse M, Doengi M, Becker A, et al. Midbody positioning and distance between daughter nuclei enable unequivocal identification of cardiomyocyte cell division in mice. Circ Res 2018;123:1039-52.
6. Bae J, Paltzer WG, Mahmoud AI. The role of metabolism in heart failure and regeneration. Front Cardiovasc Med 2021;8:702920.
7. Rowton M, Guzzetta A, Rydeen AB, Moskowitz IP. Control of cardiomyocyte differentiation timing by intercellular signaling pathways. Semin Cell Dev Biol 2021;118:94-106.
8. Derrick CJ, Noël ES. The ECM as a driver of heart development and repair. Development 2021;148:dev191320.
9. Amram AV, Cutie S, Huang GN. Hormonal control of cardiac regenerative potential. Endocr Connect 2021;10:R25-35.
